Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy

Anti-tumor necrosis factor alpha (ATA) therapy plays a significant role in the treatment of moderate to severe inflammatory bowel disease (IBD). There are concerns regarding risks associated with their use, including malignancy and, specifically, lymphoma. Many previous studies have sought to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahmus, Jessica, Rosario, Michelle, Clarke, Kofi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501969/
https://www.ncbi.nlm.nih.gov/pubmed/32982364
http://dx.doi.org/10.2147/CEG.S237646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501969/
https://www.ncbi.nlm.nih.gov/pubmed/32982364
http://dx.doi.org/10.2147/CEG.S237646

Ejemplares similares